CVS Health Co. (NYSE:CVS) Shares Sold by Curbstone Financial Management Corp

Curbstone Financial Management Corp lowered its position in CVS Health Co. (NYSE:CVS) by 9.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,728 shares of the pharmacy operator’s stock after selling 1,718 shares during the quarter. Curbstone Financial Management Corp’s holdings in CVS Health were worth $1,133,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Assenagon Asset Management S.A. increased its stake in shares of CVS Health by 310.8% in the first quarter. Assenagon Asset Management S.A. now owns 3,523,824 shares of the pharmacy operator’s stock valued at $238,739,000 after purchasing an additional 2,666,029 shares during the period. MV Capital Management Inc. increased its stake in shares of CVS Health by 63.9% in the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator’s stock valued at $50,000 after purchasing an additional 289 shares during the period. Integrated Advisors Network LLC increased its stake in shares of CVS Health by 162.1% in the first quarter. Integrated Advisors Network LLC now owns 62,545 shares of the pharmacy operator’s stock valued at $4,237,000 after purchasing an additional 38,678 shares during the period. Atwood & Palmer Inc. increased its stake in shares of CVS Health by 228.0% in the first quarter. Atwood & Palmer Inc. now owns 820 shares of the pharmacy operator’s stock valued at $56,000 after purchasing an additional 570 shares during the period. Finally, SG Americas Securities LLC increased its stake in shares of CVS Health by 606.2% during the first quarter. SG Americas Securities LLC now owns 203,407 shares of the pharmacy operator’s stock valued at $13,781,000 after acquiring an additional 174,606 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling

In other news, Director Guy P. Sansone acquired 1,570 shares of the firm’s stock in a transaction on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director now owns 12,007 shares of the company’s stock, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.22% of the company’s stock.

CVS Health Stock Up 0.5%

CVS Health stock opened at $64.21 on Wednesday. The firm has a market cap of $81.22 billion, a price-to-earnings ratio of 17.54, a P/E/G ratio of 0.98 and a beta of 0.56. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The firm has a fifty day moving average price of $65.06 and a two-hundred day moving average price of $60.01.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.31 earnings per share. As a group, analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.14%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health’s dividend payout ratio (DPR) is presently 63.48%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday, February 12th. Royal Bank of Canada raised their price objective on shares of CVS Health from $74.00 to $81.00 and gave the company an “outperform” rating in a research note on Monday, May 5th. Argus set a $77.00 price objective on shares of CVS Health in a research note on Tuesday, February 18th. Robert W. Baird raised their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a “neutral” rating in a research note on Tuesday, April 15th. Finally, Piper Sandler raised their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an “overweight” rating in a research note on Friday, March 21st. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $74.75.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.